Last: | $1.16 |
---|---|
Change Percent: | -0.91% |
Open: | $1.11 |
Close: | $1.16 |
High: | $1.2 |
Low: | $1.1 |
Volume: | 25,903,160 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.16 | $1.11 | $1.16 | $1.2 | $1.1 | 25,903,160 | 03-28-2024 |
$1.1 | $1.07 | $1.1 | $1.13 | $1.06 | 16,549,189 | 03-27-2024 |
$1.07 | $1.09 | $1.07 | $1.12 | $1.07 | 11,310,606 | 03-26-2024 |
$1.09 | $1.07 | $1.09 | $1.1 | $1.06 | 11,285,998 | 03-25-2024 |
$1.07 | $1.12 | $1.07 | $1.13 | $1.07 | 13,280,948 | 03-22-2024 |
$1.14 | $1.17 | $1.14 | $1.19 | $1.11 | 13,050,398 | 03-21-2024 |
$1.15 | $1.07 | $1.15 | $1.17 | $1.06 | 15,412,848 | 03-20-2024 |
$1.09 | $1.08 | $1.09 | $1.11 | $1.07 | 16,231,838 | 03-19-2024 |
$1.09 | $1.07 | $1.09 | $1.11 | $1.03 | 21,144,700 | 03-18-2024 |
$1.08 | $1.07 | $1.08 | $1.11 | $1.06 | 41,808,056 | 03-15-2024 |
$1.06 | $1.17 | $1.06 | $1.17 | $1.05 | 41,230,821 | 03-14-2024 |
$1.17 | $1.18 | $1.17 | $1.23 | $1.16 | 15,643,526 | 03-13-2024 |
$1.17 | $1.22 | $1.17 | $1.22 | $1.17 | 21,493,204 | 03-12-2024 |
$1.22 | $1.21 | $1.22 | $1.26 | $1.19 | 18,393,992 | 03-11-2024 |
$1.22 | $1.215 | $1.22 | $1.28 | $1.18 | 21,187,288 | 03-08-2024 |
$1.2 | $1.22 | $1.2 | $1.24 | $1.18 | 17,828,711 | 03-07-2024 |
$1.22 | $1.2 | $1.22 | $1.24 | $1.19 | 17,970,361 | 03-06-2024 |
$1.15 | $1.23 | $1.15 | $1.26 | $1.13 | 50,418,732 | 03-05-2024 |
$1.26 | $1.32 | $1.26 | $1.32 | $1.25 | 32,497,560 | 03-04-2024 |
$1.29 | $1.28 | $1.29 | $1.4 | $1.22 | 60,417,289 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth...
BOSTON, March 28, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE:DNA), which is building the leading platform for cell programming and biosecurity, tod...
Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments PR Newswire BOSTON , March 28, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurit...